Form 4: Clorox COO's Stock Transactions: Vesting & Tax Sales
Insider Transaction Report
Clorox's Chief Operating Officer, Eric H. Reynolds, acquired 15,489 shares through a performance unit grant settlement while simultaneously disposing of 10,191 shares for tax obligations.
Summary
- Eric H. Reynolds, EVP Chief Operating Officer of Clorox Co. (CLX), reported changes in beneficial ownership on October 3, 2025.
- Reynolds acquired 15,489 shares of Common Stock at $122.25 per share, resulting from the settlement of a 2022 Performance Unit Grant that vested on this date.
- Concurrently, 10,191 shares were disposed of at $122.25 per share to satisfy tax obligations related to the vesting of restricted stock (2,755 shares) and performance stock units (7,436 shares).
- Following these transactions, Reynolds' direct beneficial ownership stands at 69,313 shares of Common Stock.
- This total includes 739 shares acquired through the company's Stock Incentive Plan's dividend reinvestment feature.
Sentiment
Score: 7
Explanation: The filing reflects routine executive compensation events, specifically the vesting of performance units and subsequent tax-related share dispositions. The net increase in beneficial ownership from the vesting event (15,489 shares acquired vs. 10,191 shares disposed for taxes) is a standard positive outcome of long-term incentive plans, aligning executive interests with shareholder value.
Positives
- EVP Chief Operating Officer Eric H. Reynolds acquired a net of 5,298 shares (15,489 acquired minus 10,191 disposed for taxes) through the vesting of a 2022 Performance Unit Grant, reflecting the successful achievement of long-term incentive goals.
- The vesting and acquisition of shares at $122.25 per share demonstrate the continued alignment of executive interests with shareholder value.
Negatives
- No inherently negative aspects identified, as dispositions were solely for tax withholding purposes related to vested equity.
Stakeholder Impact
- Shareholders: Reflects standard executive compensation practices and a net increase in insider ownership from the vesting event, aligning executive incentives with company performance.
Key Dates
| Date | Description |
|---|---|
| 10/03/2025 | Date of earliest transaction, including vesting of 2022 Performance Unit Grant and related stock acquisitions/dispositions. |
| 10/07/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThis Form 4 filing details routine executive compensation events, specifically the vesting of performance units and subsequent share dispositions for tax purposes. It does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. The net increase in beneficial ownership from the vesting event is a standard outcome of long-term incentive plans.
Keywords
CLX, Clorox, insider trading, Form 4, beneficial ownership, stock acquisition, stock disposition, executive compensation, Eric H. Reynolds
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.